サマリー

自閉症スペクトラム障害治療薬の世界市場 2023-2027
自閉症スペクトラム障害治療薬市場は2022-2027年に7億7,265万米ドルで成長し、予測期間中のCAGRは7.2%で加速すると予測されます。この調査レポートは、自閉症スペクトラム障害治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。ASDの有病率の増加、官民連携の増加、自閉症スペクトラム障害に対する意識の高まりが市場を牽引しています。
Technavio社の自閉症スペクトラム障害治療薬市場は以下のように分類されます：
流通チャネル別
- 小売薬局
- 病院薬局
- オンライン薬局
タイプ別
- 覚せい剤
- 選択的セロトニン再取り込み阻害薬
- 抗精神病薬
- 睡眠薬
- その他
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、ASDの治療における個別化医療への関心の高まりが、今後数年間の自閉症スペクトラム障害治療薬市場の成長を促進する主な理由の1つであると特定している。また、デジタル治療薬の使用の増加や、ASDに対する酵素補充療法（ERT）の探求の増加は、市場の大きな需要につながるでしょう。
当レポートでは、自閉症スペクトラム障害治療薬市場について、以下の分野をカバーしています：
- 自閉症スペクトラム障害治療薬市場のサイジング
- 自閉症スペクトラム障害治療薬市場予測
- 自閉症スペクトラム障害治療薬市場産業分析
強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って本レポートでは、AutismSTEP、Bristol Myers Squibb Co.、CureMark LLC、F. Hoffmann La Roche Ltd.、Fraser、Jazz Pharmaceuticals Plc、Johnson and Johnson Services Inc.、Les Laboratoires Servier SAS、Neurim Pharmaceuticals Ltd.、Novartis AG、Oryzon Genomics SA、Otsuka Holdings Co.Ltd.、PaxMedica Inc.、Q BioMed Inc.、Scioto Biosciences Inc.、Spectrum Pharmaceuticals Inc.、Stalicla SA、Travere Therapeutics Inc.、Yamo Pharmaceuticals LLC、Zynerba Pharmaceuticals Inc.また、自閉症スペクトラム障害治療薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/autism-spectrum-disorder-therapeutics-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global autism spectrum disorder therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global autism spectrum disorder therapeutics market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Retail pharmacy - Market size and forecast 2022-2027
o Exhibit 34: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
o 6.4 Hospital pharmacy - Market size and forecast 2022-2027
o Exhibit 38: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
o 6.5 Online pharmacy - Market size and forecast 2022-2027
o Exhibit 42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Stimulants - Market size and forecast 2022-2027
o Exhibit 52: Chart on Stimulants - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Stimulants - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Stimulants - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Stimulants - Year-over-year growth 2022-2027 (%)
o 7.4 Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027
o Exhibit 56: Chart on Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Selective serotonin reuptake inhibitors - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Selective serotonin reuptake inhibitors - Year-over-year growth 2022-2027 (%)
o 7.5 Antipsychotic drugs - Market size and forecast 2022-2027
o Exhibit 60: Chart on Antipsychotic drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Antipsychotic drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Antipsychotic drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Antipsychotic drugs - Year-over-year growth 2022-2027 (%)
o 7.6 Sleep medications - Market size and forecast 2022-2027
o Exhibit 64: Chart on Sleep medications - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Sleep medications - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Sleep medications - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Sleep medications - Year-over-year growth 2022-2027 (%)
o 7.7 Others - Market size and forecast 2022-2027
o Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Type
o Exhibit 72: Market opportunity by Type ($ million)
o Exhibit 73: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 77: Chart on Geographic comparison
o Exhibit 78: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 115: Market opportunity By Geographical Landscape ($ million)
o Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 117: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 119: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 120: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 121: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 122: Matrix on vendor position and classification
o 12.3 Bristol Myers Squibb Co.
o Exhibit 123: Bristol Myers Squibb Co. - Overview
o Exhibit 124: Bristol Myers Squibb Co. - Product / Service
o Exhibit 125: Bristol Myers Squibb Co. - Key news
o Exhibit 126: Bristol Myers Squibb Co. - Key offerings
o 12.4 CureMark LLC
o Exhibit 127: CureMark LLC - Overview
o Exhibit 128: CureMark LLC - Product / Service
o Exhibit 129: CureMark LLC - Key offerings
o 12.5 F. Hoffmann La Roche Ltd.
o Exhibit 130: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 131: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 132: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 133: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 134: F. Hoffmann La Roche Ltd. - Segment focus
o 12.6 Jazz Pharmaceuticals Plc
o Exhibit 135: Jazz Pharmaceuticals Plc - Overview
o Exhibit 136: Jazz Pharmaceuticals Plc - Product / Service
o Exhibit 137: Jazz Pharmaceuticals Plc - Key news
o Exhibit 138: Jazz Pharmaceuticals Plc - Key offerings
o 12.7 Les Laboratoires Servier SAS
o Exhibit 139: Les Laboratoires Servier SAS - Overview
o Exhibit 140: Les Laboratoires Servier SAS - Business segments
o Exhibit 141: Les Laboratoires Servier SAS - Key offerings
o Exhibit 142: Les Laboratoires Servier SAS - Segment focus
o 12.8 Neurim Pharmaceuticals Ltd.
o Exhibit 143: Neurim Pharmaceuticals Ltd. - Overview
o Exhibit 144: Neurim Pharmaceuticals Ltd. - Product / Service
o Exhibit 145: Neurim Pharmaceuticals Ltd. - Key offerings
o 12.9 Novartis AG
o Exhibit 146: Novartis AG - Overview
o Exhibit 147: Novartis AG - Business segments
o Exhibit 148: Novartis AG - Key offerings
o Exhibit 149: Novartis AG - Segment focus
o 12.10 Oryzon Genomics SA
o Exhibit 150: Oryzon Genomics SA - Overview
o Exhibit 151: Oryzon Genomics SA - Product / Service
o Exhibit 152: Oryzon Genomics SA - Key offerings
o 12.11 Otsuka Holdings Co. Ltd.
o Exhibit 153: Otsuka Holdings Co. Ltd. - Overview
o Exhibit 154: Otsuka Holdings Co. Ltd. - Business segments
o Exhibit 155: Otsuka Holdings Co. Ltd. - Key offerings
o Exhibit 156: Otsuka Holdings Co. Ltd. - Segment focus
o 12.12 Q BioMed Inc.
o Exhibit 157: Q BioMed Inc. - Overview
o Exhibit 158: Q BioMed Inc. - Product / Service
o Exhibit 159: Q BioMed Inc. - Key offerings
o 12.13 Scioto Biosciences Inc.
o Exhibit 160: Scioto Biosciences Inc. - Overview
o Exhibit 161: Scioto Biosciences Inc. - Product / Service
o Exhibit 162: Scioto Biosciences Inc. - Key offerings
o 12.14 Spectrum Pharmaceuticals Inc.
o Exhibit 163: Spectrum Pharmaceuticals Inc. - Overview
o Exhibit 164: Spectrum Pharmaceuticals Inc. - Product / Service
o Exhibit 165: Spectrum Pharmaceuticals Inc. - Key offerings
o 12.15 Stalicla SA
o Exhibit 166: Stalicla SA - Overview
o Exhibit 167: Stalicla SA - Product / Service
o Exhibit 168: Stalicla SA - Key offerings
o 12.16 Yamo Pharmaceuticals LLC
o Exhibit 169: Yamo Pharmaceuticals LLC - Overview
o Exhibit 170: Yamo Pharmaceuticals LLC - Product / Service
o Exhibit 171: Yamo Pharmaceuticals LLC - Key offerings
o 12.17 Zynerba Pharmaceuticals Inc.
o Exhibit 172: Zynerba Pharmaceuticals Inc. - Overview
o Exhibit 173: Zynerba Pharmaceuticals Inc. - Product / Service
o Exhibit 174: Zynerba Pharmaceuticals Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 175: Inclusions checklist
o Exhibit 176: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 177: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 178: Research methodology
o Exhibit 179: Validation techniques employed for market sizing
o Exhibit 180: Information sources
o 13.5 List of abbreviations
o Exhibit 181: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global autism spectrum disorder therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Type - Market share 2022-2027 (%)
Exhibits49: Data Table on Type - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Stimulants - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Stimulants - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Stimulants - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Stimulants - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Selective serotonin reuptake inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Selective serotonin reuptake inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Selective serotonin reuptake inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Antipsychotic drugs - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Antipsychotic drugs - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Antipsychotic drugs - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Antipsychotic drugs - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Sleep medications - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Sleep medications - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Sleep medications - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Sleep medications - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits72: Market opportunity by Type ($ million)
Exhibits73: Data Table on Market opportunity by Type ($ million)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ million)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits117: Impact of drivers and challenges in 2022 and 2027
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Bristol Myers Squibb Co. - Overview
Exhibits124: Bristol Myers Squibb Co. - Product / Service
Exhibits125: Bristol Myers Squibb Co. - Key news
Exhibits126: Bristol Myers Squibb Co. - Key offerings
Exhibits127: CureMark LLC - Overview
Exhibits128: CureMark LLC - Product / Service
Exhibits129: CureMark LLC - Key offerings
Exhibits130: F. Hoffmann La Roche Ltd. - Overview
Exhibits131: F. Hoffmann La Roche Ltd. - Business segments
Exhibits132: F. Hoffmann La Roche Ltd. - Key news
Exhibits133: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits135: Jazz Pharmaceuticals Plc - Overview
Exhibits136: Jazz Pharmaceuticals Plc - Product / Service
Exhibits137: Jazz Pharmaceuticals Plc - Key news
Exhibits138: Jazz Pharmaceuticals Plc - Key offerings
Exhibits139: Les Laboratoires Servier SAS - Overview
Exhibits140: Les Laboratoires Servier SAS - Business segments
Exhibits141: Les Laboratoires Servier SAS - Key offerings
Exhibits142: Les Laboratoires Servier SAS - Segment focus
Exhibits143: Neurim Pharmaceuticals Ltd. - Overview
Exhibits144: Neurim Pharmaceuticals Ltd. - Product / Service
Exhibits145: Neurim Pharmaceuticals Ltd. - Key offerings
Exhibits146: Novartis AG - Overview
Exhibits147: Novartis AG - Business segments
Exhibits148: Novartis AG - Key offerings
Exhibits149: Novartis AG - Segment focus
Exhibits150: Oryzon Genomics SA - Overview
Exhibits151: Oryzon Genomics SA - Product / Service
Exhibits152: Oryzon Genomics SA - Key offerings
Exhibits153: Otsuka Holdings Co. Ltd. - Overview
Exhibits154: Otsuka Holdings Co. Ltd. - Business segments
Exhibits155: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits156: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits157: Q BioMed Inc. - Overview
Exhibits158: Q BioMed Inc. - Product / Service
Exhibits159: Q BioMed Inc. - Key offerings
Exhibits160: Scioto Biosciences Inc. - Overview
Exhibits161: Scioto Biosciences Inc. - Product / Service
Exhibits162: Scioto Biosciences Inc. - Key offerings
Exhibits163: Spectrum Pharmaceuticals Inc. - Overview
Exhibits164: Spectrum Pharmaceuticals Inc. - Product / Service
Exhibits165: Spectrum Pharmaceuticals Inc. - Key offerings
Exhibits166: Stalicla SA - Overview
Exhibits167: Stalicla SA - Product / Service
Exhibits168: Stalicla SA - Key offerings
Exhibits169: Yamo Pharmaceuticals LLC - Overview
Exhibits170: Yamo Pharmaceuticals LLC - Product / Service
Exhibits171: Yamo Pharmaceuticals LLC - Key offerings
Exhibits172: Zynerba Pharmaceuticals Inc. - Overview
Exhibits173: Zynerba Pharmaceuticals Inc. - Product / Service
Exhibits174: Zynerba Pharmaceuticals Inc. - Key offerings
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations